Literature DB >> 9536955

The relationship between intrahepatic portal systemic shunts and microsphere induced portal hypertension in the rat liver.

X Li1, I S Benjamin, B Alexander.   

Abstract

BACKGROUND: Portal hypertension is associated with gross haemodynamic disturbances characterised by high cardiac output, low peripheral vascular resistance, increased splanchnic blood flow, and portal systemic shunting. AIMS: To study the relationship between intrahepatic portal systemic shunts and microsphere induced portal hypertension in the rat liver.
METHODS: Different sized microspheres were sequentially injected into the portal vein of male Wistar rats.
RESULTS: Steady state portal venous pressure was increased by 102.2 (35.6)% (14.9 (3.6) mm Hg) and 272.3 (78.0)% (24.0 (2.2) mm Hg) above the basal pressure following sequential injections of 15 and 80 microns diameter microspheres, respectively. Sequential injection of 15, 40, and 80 microns diameter microspheres in either ascending or descending order of size did not generate further increases in portal venous pressure. A single injection of 1.8 x 10(5) 80 microns microspheres consistently produced a steady state portal venous pressure of 19.0 (1.3) mm Hg but did not approach the much higher value of 36.6 (43.2) mm Hg measured during clamping of the portal vein. These data indicate that the opening of patent intrahepatic shunts was responsible for the reduced pressures observed during microsphere injections and further evidence for this was provided by the location of microspheres in the pulmonary vascular bed. The elevation in portal venous pressure achieved by microsphere injections was not significantly different to that produced in rats subjected to partial portal vein ligation (20.7 (0.5) mm Hg, p > 0.05). Wedged hepatic venous pressure decreased from 6.7 (0.7) to 3.0 (0.6) mm Hg following injection of 80 microns microspheres, suggesting a decrease in total hepatic blood flow. Conversely, injection of 15 microns microspheres induced an increase in wedged hepatic venous pressure from 7.0 (1.0) mm Hg to 12.4 (1.8) mm Hg, indicating a localised redistribution of blood flow at the presinusoidal level of the portal venous vascular network and increased intrahepatic shunt flow.
CONCLUSION: It is suggested that there may be a protective pathophysiological role for these shunts when the liver is subjected to changes which induce acute portal hypertension.

Entities:  

Mesh:

Year:  1998        PMID: 9536955      PMCID: PMC1726987          DOI: 10.1136/gut.42.2.276

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Wedged and free hepatic venous pressure measured with a balloon catheter.

Authors:  R J Groszmann; M Glickman; A T Blei; E Storer; H O Conn
Journal:  Gastroenterology       Date:  1979-02       Impact factor: 22.682

2.  A method for graded portal vein stenosis in rats: survival related to degree of stenosis.

Authors:  A O Myking; J F Halvorsen
Journal:  Eur Surg Res       Date:  1973       Impact factor: 1.745

Review 3.  Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response.

Authors:  W W Lautt
Journal:  Am J Physiol       Date:  1985-11

Review 4.  Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis?

Authors:  R Pérez Tamayo
Journal:  Hepatology       Date:  1983 Jan-Feb       Impact factor: 17.425

5.  Increased blood flow through the portal system in cirrhotic rats.

Authors:  J Vorobioff; J E Bredfeldt; R J Groszmann
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

6.  Dopamine D1-like receptor-mediated presynaptic inhibition of excitatory transmission onto rat magnocellular basal forebrain neurones.

Authors:  T Momiyama; J A Sim; D A Brown
Journal:  J Physiol       Date:  1996-08-15       Impact factor: 5.182

7.  Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium.

Authors:  S S Lee; C Girod; A Braillon; A Hadengue; D Lebrec
Journal:  Am J Physiol       Date:  1986-08

8.  A new method for the measurement of intrahepatic shunts.

Authors:  J C Hoefs; T B Reynolds; P Pare; I Sakimura
Journal:  J Lab Clin Med       Date:  1984-03

9.  Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat.

Authors:  A J Wood; J P Villeneuve; R A Branch; L W Rogers; D G Shand
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

10.  Systemic and splanchnic hemodynamic disturbances in conscious rats with experimental liver cirrhosis without ascites.

Authors:  D Fernández-Muñoz; C Caramelo; J C Santos; A Blanchart; L Hernando; J M López-Novoa
Journal:  Am J Physiol       Date:  1985-09
View more
  5 in total

1.  Hepato-cardiovascular response and its regulation.

Authors:  Xiang-Nong Li; Irving S Benjamin; Barry Alexander
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Characterization and evolution of intestine injury at the anhepatic phase in portal hypertensive rats.

Authors:  Guijun Ren; Xiaoye Yuan; Xin Zhao; Qingchun Hao; Jinglin Cao; Yang Wang; Qingjun Gao; Jian Dou; Qiang Zeng
Journal:  Exp Ther Med       Date:  2018-09-27       Impact factor: 2.447

3.  Location and function of intrahepatic shunts in anaesthetised rats.

Authors:  X Li; I S Benjamin; R Naftalin; B Alexander
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

4.  Differentiation between the effects of unprocessed portal blood and reduced liver function on brain indole amine metabolism in the portacaval shunted rat.

Authors:  B Alexander; M Aslam; A Nobin; I S Benjamin
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

5.  Acoustic Radiation Force Impulse (ARFI) Elastography and Serological Markers in Assessment of Liver Fibrosis and Free Portal Pressure in Patients with Hepatitis B.

Authors:  Jun Li; Jie Yu; Xin-Yu Peng; Ting-Ting Du; Jia-Jia Wang; Jin Tong; Gui-Lin Lu; Xiang-Wei Wu
Journal:  Med Sci Monit       Date:  2017-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.